glp-1 and macular degeneration Breaking: Use of Semaglutide increases the chances of #glp1 #ozempic #maculardegeneration degeneration GLP-1 Receptor Agonists and the

Novo Nordisk filed for FDA approval in December 2025

The highest doses of medications like tirzepatide have shown even more impressive results, with some patients losing up to twenty-two percent of their initial weight

Food Chem Toxicol 70:5460

4,17,18 Based on the importance and complexities of managing dietary patterns for patients with T2D and GLP1 RA use, health insurance coverage of evidence-based, clinically indicated Food is Medicine therapies is critical to ensure all patients have equitable access to a health-promoting dietary pattern to manage their disease in conjunction with GLP1 RAs and related therapies

Using the correct dose and starting slow will be key during your treatment

In rare cases, consuming extremely large volumes of food very quickly while on semaglutide could theoretically cause gastric distension or aspiration, but this would require ignoring severe warning signals from your body